Sugi Predict

Sugi Predict / Compounds / SCHEMBL29554654

SCHEMBL29554654

SCHEMBL29554654

N[C@H](Cc1ccc2ccccc2c1)C(=O)O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC7A5 Q01650 4/20 0.65
▸ PTGS1 P23219 2/20 0.65
▸ ALPI P09923 1/20 0.65
▸ PKM P14618 1/20 0.65
▸ XIAP P98170 1/20 0.65
▸ HTR2A P28223 2/20 0.60
▸ PTPN1 P18031 1/20 0.60
▸ KDM4E B2RXH2 1/20 0.60
▸ USP2 O75604 1/20 0.60
▸ EGFR P00533 1/20 0.60
▸ LCK P06239 1/20 0.60
▸ FYN P06241 1/20 0.60
▸ ADORA3 P0DMS8 1/20 0.60
▸ ALOX15 P16050 1/20 0.60
▸ PTGS2 P35354 1/20 0.60
▸ RECQL P46063 1/20 0.60
▸ HIF1A Q16665 1/20 0.60
▸ HSD17B10 Q99714 1/20 0.60
▸ TDP1 Q9NUW8 1/20 0.60
▸ HTR2C P28335 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL210104 1.00 SLC7A5 (0.65) SLC7A5PTGS1ALPIPKMXIAP
SCHEMBL29401985 1.00 SLC7A5 (0.65) SLC7A5PTGS1ALPIPKMXIAP
SCHEMBL93304 1.00 SLC7A5 (0.65) SLC7A5PTGS1ALPIPKMXIAP
SCHEMBL29375097 1.00 SLC7A5 (0.65) SLC7A5PTGS1ALPIPKMXIAP
SCHEMBL837890 1.00 SLC7A5 (0.65) SLC7A5PTGS1ALPIPKMXIAP
SCHEMBL29584308 1.00 SLC7A5 (0.65) SLC7A5PTGS1ALPIPKMXIAP
SCHEMBL93303 1.00 SLC7A5 (0.65) SLC7A5PTGS1ALPIPKMXIAP
Hydrochloric Acid SCHEMBL5967402 0.98 SLC7A5 (0.62) SLC7A5PTGS1ALPIPKMXIAP
Hydrochloric Acid SCHEMBL2344880 0.98 SLC7A5 (0.62) SLC7A5PTGS1ALPIPKMXIAP
Hydrochloric Acid SCHEMBL29398635 0.98 SLC7A5 (0.62) SLC7A5PTGS1ALPIPKMXIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025123056-A1 NON-NATURALLY OCCURRING MELANOCORTIN ANALOGS AND ASSOCIATED METHODS ENDEVICA BIO, INC. (US) 2025-06-12 — — WO claimed
WO-2025123055-A1 NON-NATURALLY OCCURRING MELANOCORTIN ANALOGS AND ASSOCIATED METHODS FOR MODULATING WEIGHT GAIN ENDEVICA BIO, INC. (US) 2025-06-12 — — WO claimed
CN-114641272-B Skin lightening compositions 贝雅欧若拉实验室公司 2024-06-04 — — CN claimed
CN-117677405-A Targeting system with higher absorptivity 科尔泰格知识产权有限公司 2024-03-08 — — CN claimed
CN-115851645-A Proteobacterium vulgaris meso-diaminopimelate dehydrogenase mutant and application thereof 江南大学 2023-03-28 — — CN claimed
US-20220289794-A1 SYNTHETIC ANTIMICROBIAL PEPTIDES AJK BIOPHARMACEUTICAL LLC (US) 2022-09-15 — — US claimed
EP-4021476-A1 SYNTHETIC ANTIMICROBIAL PEPTIDES AJK Biopharmaceutical, LLC (US) 2022-07-06 — — EP claimed
CN-114641272-A Skin lightening compositions 贝雅欧若拉实验室公司 2022-06-17 — — CN claimed
US-12613237-B2 Biosensors for detecting arrestin signaling MONTANA MOLECULAR, LLC (US) 2026-04-28 — — US disclosed
CN-120189144-A Deep learning-based interleaving multiplexing method and PET detector 深圳湾实验室 2025-06-24 — — CN disclosed
WO-2025123056-A1 NON-NATURALLY OCCURRING MELANOCORTIN ANALOGS AND ASSOCIATED METHODS ENDEVICA BIO, INC. (US) 2025-06-12 — — WO disclosed
WO-2025123055-A1 NON-NATURALLY OCCURRING MELANOCORTIN ANALOGS AND ASSOCIATED METHODS FOR MODULATING WEIGHT GAIN ENDEVICA BIO, INC. (US) 2025-06-12 — — WO disclosed
US-20250171497-A1 ULTRA-PURE AGONISTS OF GUANYLATE CYCLASE C, METHOD OF MAKING AND USING SAME BAUSCH HEALTH IRELAND LIMITED (IE) 2025-05-29 — — US disclosed
EP-4551566-A1 NEW SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS Les Laboratoires Servier (FR) 2025-05-14 — — EP disclosed
WO-2022180126-A1 TARGETING SYSTEM WITH IMPROVED UPTAKE CORETAG HOLDING AG (CH) 2022-09-01 — — WO disclosed
EP-4021476-A1 SYNTHETIC ANTIMICROBIAL PEPTIDES AJK Biopharmaceutical, LLC (US) 2022-07-06 — — EP disclosed
CN-114641486-A For reducing CB1Peptide compounds of side effects of receptor agonists 庞培法布拉大学 2022-06-17 — — CN disclosed
CN-114641272-A Skin lightening compositions 贝雅欧若拉实验室公司 2022-06-17 — — CN disclosed
US-11319346-B2 Ultra-pure agonists of guanylate cyclase C, method of making and using same BAUSCH HEALTH IRELAND LIMITED (IE) 2022-05-03 — — US disclosed
US-20220119449-A1 ULTRA-PURE AGONISTS OF GUANYLATE CYCLASE C, METHOD OF MAKING AND USING SAME BAUSCH HEALTH IRELAND LIMITED (IE) 2022-04-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250171497-A1 ULTRA-PURE AGONISTS OF GUANYLATE CYCLASE C, METHOD OF MAKING AND USING SAME GUCY1A1, GUCY1A2, GUCY1B1 SLC7A5 3477/4885PTGS1 262/4885ALPI 4674/4885
US-20220289794-A1 SYNTHETIC ANTIMICROBIAL PEPTIDES VIP, HM13, NGLY1 SLC7A5 1411/4885PTGS1 4504/4885ALPI 3137/4885
US-20220119449-A1 ULTRA-PURE AGONISTS OF GUANYLATE CYCLASE C, METHOD OF MAKING AND USING SAME GUCY1A1, GUCY1A2, GUCY1B1 SLC7A5 3477/4885PTGS1 262/4885ALPI 4674/4885
US-12613237-B2 Biosensors for detecting arrestin signaling ARRB1, RGS19, GPR55 SLC7A5 187/4885PTGS1 4428/4885ALPI 2419/4885
US-11319346-B2 Ultra-pure agonists of guanylate cyclase C, method of making and using same GUCY1A1, GUCY1A2, GUCY1B1 SLC7A5 3477/4885PTGS1 262/4885ALPI 4674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.